BRAINSTORM CELL THERAPEUTICS INC. Severance Costs
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Severance Costs of $910.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2024-04-01
- BRAINSTORM CELL THERAPEUTICS INC. severance costs for the quarter ending 2013-09-30 was $22.00K, a 340.00% increase year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. severance costs for the quarter ending 2013-06-30 was $9.00K.
- BRAINSTORM CELL THERAPEUTICS INC. severance costs for the quarter ending 2012-09-30 was $5.00K.
- BRAINSTORM CELL THERAPEUTICS INC. severance costs for the quarter ending 2012-06-30 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. severance costs for fiscal 2023 was $910.00K.
| Period end | Severance Costs 3 month | Severance Costs 6 month | Severance Costs 9 month | Severance Costs 12 month | Severance Costs 153 month | Severance Costs 156 month |
|---|---|---|---|---|---|---|
| 2023-12-31 | $910.00K 10-K · filed 2024-04-01 | |||||
| 2013-09-30 | $22.00K 10-Q · filed 2013-11-14 | $31.00K derived: sum of 2 quarters · filed 2013-11-14 | $29.00K 10-Q · filed 2013-11-14 | $46.00K 10-Q · filed 2013-11-14 | ||
| 2013-06-30 | $9.00K 10-Q · filed 2013-08-14 | $7.00K 10-Q · filed 2013-08-14 | $24.00K 10-Q · filed 2013-08-14 | |||
| 2012-09-30 | $5.00K 10-Q · filed 2013-11-14 | $5.00K derived: sum of 2 quarters · filed 2013-11-14 | $6.00K 10-Q · filed 2013-11-14 | |||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-14 | $1.00K 10-Q · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |